|Annual Meeting Home||Past & Future Meetings|
Hyperbaric Oxygen Therapy for Necrotizing Soft Tissue Infections: a Transatlantic Story
*Ali Y Mejaddam1, *Poya Ghorbani2, *Louis Riddez2, *Daniel Yeh1, *Marc A de Moya1, George C Velmahos1
1Massachusetts General Hospital, Boston, MA;2Karolinska University Hospital, Stockholm, Sweden
OBJECTIVE: To evaluate if hyperbaric oxygen therapy (HBO) as an adjunctive treatment of necrotizing soft tissue infections (NSTI) is associated with improved survival.
By accounting for differences between the groups, logistic regression identified HBO therapy as an independent predictor of survival (OR: 5.7, 95% CI: 1.1-29.9, p=0.038).
CONCLUSIONS: HBO therapy was associated with improved survival, fewer debridements, and increased rate of limb salvage in patients with NSTI.
Back to Annual Meeting Program
IMPORTANT DATESAbstract Submission Deadline:
May 5, 2014
August 13, 2014
Early Bird Registration Deadline:
August 11, 2014